Iohexol

Dexketamine HCl is a kind of anesthetic drugs.
It is still in R&D stage.

Dutasteride is a triple 5α-reductase inhibitor that inhibits conversion of testosterone to dihydrotestosterone. It is used to treat benign prostatic hyperplasia. It increases the risk of erectile dysfunction and decreased sexual desire.

Dutasteride API is...

Gadobutrol is a gadolinium-based MRI contrast agent.
It is approved by NMPA.
US-DMF is available.

Gefitinib is a drug used for certain breast, lung and other cancers. 

It is in R&D stage.

Glycopyrronium bromide is a medication of the muscarinic anticholinergic group. It does not cross the blood–brain barrier and consequently has no to few central effects. A synthetic quaternary amine, it is available in oral and intravenous forms and as...

Indacaterol is an ultra-long-acting beta-adrenoceptor agonist. It is for the treatment of chronic obstructive pulmonary disease (COPD) (long-term data in patients with asthma are thus far lacking). It is delivered as an aerosol formulation through a dry powder inhaler. qq...

Mycophenolate Sodium is an immunosuppressant drug used to prevent rejection in organ transplantation. It inhibits an enzyme needed for the growth of T cells and B cells.

It is in R&D stage.

Obeticholic acid is a semi-synthetic bile acid analogue which has the chemical structure 6α-ethyl-chenodeoxycholic acid. It is used as a drug to treat primary biliary cholangitis.

It is in R&D stage.

Parecoxib is a water-soluble and injectable prodrug of valdecoxib. 

It is in R&D stage.

Rolapitant is used for the prevention of delayed nausea and vomiting associated with initial and repeat courses of emetogenic cancer chemotherapy.

It is in R&D stage.

Tolvaptan is a selective, competitive vasopressin receptor 2 antagonist used to treat hyponatremia (low blood sodium levels) associated with congestive heart failure, cirrhosis, and the syndrome of inappropriate antidiuretic hormone (SIADH).

Tolvapta...

Zinc Acetate is commonly used in chemical synthesis and as dietary supplements.

It is in R&D stage.

Hengrui Medicine is dedicated to research, developing, and promoting innovative medicine with high quality.

For APIs, we got approvals from US-FDA, EDQM, PMDA and TGA.

For FDFs, we got approvals from US-FDA, EU and PMDA.